Osteosarcoma: biochemical and endocrinological studies as a basis for its pathogenetic treatments

The paper considers data of the long-term studies of androgen metabolism, baseline serum levels of reproductive steroid hormones and their receptors in the tumor, in the blood concentrations of sex steroid-binding globulin and pituitary hormones, the expression of epidermal growth factor, its recept...

Full description

Saved in:
Bibliographic Details
Published inVestnik Rossiĭskoĭ akademii medits︠i︡nskih nauk no. 1; p. 71
Main Authors Kushlinskiĭ, N E, Trapeznikov, N N, Solov'ev, Iu N, Aliev, M D, Siniukov, P A, Durnov, L A
Format Journal Article
LanguageRussian
Published Russia (Federation) 2002
Subjects
Bone Neoplasms - chemistry
Bone Neoplasms - metabolism
Bone Neoplasms - therapy
Humans
Osteosarcoma - chemistry
Osteosarcoma - metabolism
Osteosarcoma - therapy
Online AccessGet more information

Cover

More Information
Summary:The paper considers data of the long-term studies of androgen metabolism, baseline serum levels of reproductive steroid hormones and their receptors in the tumor, in the blood concentrations of sex steroid-binding globulin and pituitary hormones, the expression of epidermal growth factor, its receptors and ligands, soluble Fas-antigen, vascular endothelial growth factor, angiogenin, and the content of calmodulin, cAMP in the osteosarcoma in 300 patients aged 14 to 56 years, which were made at the N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences. Analyzing the findings identified some lines in the study of new pathogenetic treatments for osteosarcoma, aimed at regulating androgen metabolism, correcting the cyclooxygenase pathway of arachidonic acid, the expression of receptors of epidermal growth factor and its ligands, the processes of neoangiogenesis in the tumor. A role of the above parameters in the pathogenesis of osteosarcoma is discussed.
ISSN:0869-6047